Senior insider sale
Chief Financial Officer at CENTESSA PHARMACEUTICALS PLC — senior position signals high conviction
$582.3K
41.74K shares
What this filing means
WEINHOFF GREGORY M plans to sell 41.74K shares of CENTESSA PHARMACEUTICALS PLC valued at approximately $582.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/25/2025ACC: 0001969223-25-000530
Officer· Chief Financial Officer
Since May 2021
41.74K
Shares to sell
$582.3K
Approx. market value
10K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
7/25/2025
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/25/2025 | Exercise of Stock Options Cash | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
10K
Market value
$138.6K
6/25/2025
—Completed
Units to sell
10K
Market value
$128.2K
5/27/2025
—Completed
Units to sell
11.74K
Market value
$159.9K
4/25/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
10K
Market value
$155.6K
7/25/2025
Total
Units
41.74K
Value
$582.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/25/2025 | 10K | $138.6K | — | Completed |
5/27/2025 | 10K | $128.2K | — | Completed |
4/25/2025 | 11.74K | $159.9K | — | Completed |
| Planned — Approximate Date | ||||
7/25/2025 | 10K | $155.6K | NASDAQ | Planned |
| Total | 41.74K | $582.3K | ||